|
1
|
World Health Organization (WHO). ICD-10:
International statistical classification of diseases and related
health problems/World Health Organization: 10th revision. 2nd
edition. WHO; Geneva: 2004
|
|
2
|
Kanderi T, Munakomi S and Gupta V:
Glioblastoma multiforme. StatPearls [Internet]. StatPearls
Publishing; Treasure Island, FL: 2025
|
|
3
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312.
2020.PubMed/NCBI
|
|
5
|
van Tellingen O, Yetkin-Arik B, de Gooijer
MC, Wesseling P, Wurdinger T and de Vries HE: Overcoming the
blood-brain tumor barrier for effective glioblastoma treatment.
Drug Resist Updat. 19:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hao D, Song Y, Che Z and Liu Q: Calcium
overload and in vitro apoptosis of the C6 glioma cells mediated by
sonodynamic therapy (hematoporphyrin monomethyl ether and
ultrasound). Cell Biochem Biophys. 70:1445–1452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JH, Chen ZQ, Huang Z, Zhan Q, Ren FB,
Liu JY, Yue W and Wang Z: In vitro study of low intensity
ultrasound combined with different doses of PDT: Effects on C6
glioma cells. Oncol Lett. 5:702–706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu HL, Huang CY, Chen JY, Wang HYJ, Chen
PY and Wei KC: Pharmacodynamic and therapeutic investigation of
focused ultrasound-induced blood-brain barrier opening for enhanced
temozolomide delivery in glioma treatment. PLoS One. 9:e1143112014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei KC, Chu PC, Wang HY, Huang CY, Chen
PY, Tsai HC, Lu YJ, Lee PY, Tseng IC, Feng LY, et al: Focused
ultrasound-induced blood-brain barrier opening to enhance
temozolomide delivery for glioblastoma treatment: A preclinical
study. PLoS One. 8:e589952013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lentacker I, De Cock I, Deckers R, De
Smedt SC and Moonen CTW: Understanding ultrasound induced
sonoporation: Definitions and underlying mechanisms. Adv Drug Deliv
Rev. 72:49–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Konofagou EE, Tung YS, Choi J, Deffieux T,
Baseri B and Vlachos F: Ultrasound-induced blood-brain barrier
opening. Curr Pharm Biotechnol. 13:1332–1345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Honda H, Kondo T, Zhao QL, Feril LB Jr and
Kitagawa H: Role of intracellular calcium ions and reactive oxygen
species in apoptosis induced by ultrasound. Ultrasound Med Biol.
30:683–692. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Escoffre JM, Campomanes P, Tarek M and
Bouakaz A: New insights on the role of ROS in the mechanisms of
sonoporation-mediated gene delivery. Ultrason Sonochem.
64:1049982020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao WH, Wu CH and Chen WS: Pre-treatment
with either L-carnitine or piracetam increases ultrasound-mediated
gene transfection by reducing sonoporation-associated apoptosis.
Ultrasound Med Biol. 44:1257–1265. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oesterle A, Laufs U and Liao JK:
Pleiotropic effects of statins on the cardiovascular system. Circ
Res. 120:229–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Afshari AR, Mollazadeh H, Henney NC,
Jamialahmad T and Sahebkar A: Effects of statins on brain tumors: A
review. Semin Cancer Biol. 73:116–133. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng P, Wei W, Long C and Li J:
Atorvastatin augments temozolomide's efficacy in glioblastoma via
prenylation-dependent inhibition of Ras signaling. Biochem Biophys
Res Commun. 489:293–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gaist D, Hallas J, Friis S, Hansen S and
Sørensen HT: Statin use and survival following glioblastoma
multiforme. Cancer Epidemiol. 38:722–727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen BK, Chiu HF and Yang CY: Statins are
associated with a reduced risk of brain cancer: A population-based
case-control study. Medicine (Baltimore). 95:e33922016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bouitbir J, Singh F, Charles AL,
Schlagowski AI, Bonifacio A, Echaniz-Laguna A, Geny B, Krähenbühl S
and Zoll J: Statins trigger mitochondrial reactive oxygen
species-induced apoptosis in glycolytic skeletal muscle. Antioxid
Redox Signal. 24:84–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bouitbir J, Charles AL, Echaniz-Laguna A,
Kindo M, Daussin F, Auwerx J, Piquard F, Geny B and Zoll J:
Opposite effects of statins on mitochondria of cardiac and skeletal
muscles: A ‘mitohormesis’ mechanism involving reactive oxygen
species and PGC-1. Eur Heart J. 33:1397–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Biselli-Chicote PM, Lotierzo AT, Biselli
JM, Paravino EC and Goloni-Bertollo EM: Atorvastatin increases
oxidative stress and inhibits cell migration of oral squamous cell
carcinoma in vitro. Oral Oncol. 90:109–114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY,
Wang Z, Xie X, Sun D, Chen YJ, Tabar V, et al: Gboxin is an
oxidative phosphorylation inhibitor that targets glioblastoma.
Nature. 567:341–346. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song
Y and Gao W: Celastrol mediates autophagy and apoptosis via the
ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin
Cancer Res. 38:1842019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Wang H, Xu J, Zhu J and Ding K:
Inhibition of cathepsin S induces autophagy and apoptosis in human
glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K
and JNK signaling pathways. Toxicol Lett. 228:248–259. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin H, Zhou Y, Wen C, Zhou C, Zhang W, Hu
X, Wang L, You C and Shao J: Curcumin sensitizes glioblastoma to
temozolomide by simultaneously generating ROS and disrupting
AKT/mTOR signaling. Oncol Rep. 32:1610–1616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oliveira KA, Dal-Cim T, Lopes FG, Ludka
FK, Nedel CB and Tasca CI: Atorvastatin promotes cytotoxicity and
reduces migration and proliferation of human A172 glioma cells. Mol
Neurobiol. 55:1509–1523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bayat N, Ebrahimi-Barough S,
Norouzi-Javidan A, Saberi H, Tajerian R, Ardakan MMM, Shirian S, Ai
A and Ai J: Apoptotic effect of atorvastatin in glioblastoma
spheroids tumor cultured in fibrin gel. Biomed Pharmacother.
84:1959–1966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lo CW, Desjouy C, Chen SR, Lee JL, Inserra
C, Béra JC and Chen WS: Stabilizing in vitro ultrasound-mediated
gene transfection by regulating cavitation. Ultrason Sonochem.
21:833–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brand MD, Orr AL, Perevoshchikova IV and
Quinlan CL: The role of mitochondrial function and cellular
bioenergetics in ageing and disease. Br J Dermatol. 169 (Suppl
2):S1–S8. 2013. View Article : Google Scholar
|
|
32
|
Miyoshi N, Watanabe E, Osawa T, Okuhira M,
Murata Y, Ohshima H and Nakamura Y: ATP depletion alters the mode
of cell death induced by benzyl isothiocyanate. Biochim Biophys
Acta. 1782:566–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Radstake WE, Gautam K, Van Rompay C,
Vermeesen R, Tabury K, Verslegers M, Baatout S and Baselet B:
Comparison of in vitro scratch wound assay experimental procedures.
Biochem Biophys Rep. 33:1014232023.PubMed/NCBI
|
|
34
|
Buachan P, Chularojmontri L and
Wattanapitayakul SK: Selected activities of Citrus maxima Merr.
fruits on human endothelial cells: Enhancing cell migration and
delaying cellular aging. Nutrients. 6:1618–1634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao WH, Hsiao MY, Kung Y, Liu HL, Béra
JC, Inserra C and Chen WS: TRPV4 promotes acoustic wave-mediated
BBB opening via Ca2+/PKC-δ pathway. J Adv Res. 26:15–28.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wood AKW and Sehgal CM: A review of
low-intensity ultrasound for cancer therapy. Ultrasound Med Biol.
41:905–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen H, Zhou X, Gao Y, Zheng B, Tang F and
Huang J: Recent progress in development of new sonosensitizers for
sonodynamic cancer therapy. Drug Discov Today. 19:502–509. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shibaguchi H, Tsuru H and Kuroki M and
Kuroki M: Sonodynamic cancer therapy: A non-invasive and repeatable
approach using low-intensity ultrasound with a sonosensitizer.
Anticancer Res. 31:2425–2429. 2011.PubMed/NCBI
|
|
39
|
Liang L, Xie S, Jiang L, Jin H, Li S and
Liu J: The combined effects of hematoporphyrin monomethyl ether-SDT
and doxorubicin on the proliferation of QBC939 cell lines.
Ultrasound Med Biol. 39:146–160. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Burgess A and Hynynen K: Drug delivery
across the blood-brain barrier using focused ultrasound. Expert
Opin Drug Deliv. 11:711–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu HL, Fan CH, Ting CY and Yeh CK:
Combining microbubbles and ultrasound for drug delivery to brain
tumors: Current progress and overview. Theranostics. 4:432–444.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hsiao YH, Kuo SJ, Tsai HD, Chou MC and Yeh
GP: Clinical application of high-intensity focused ultrasound in
cancer therapy. J Cancer. 7:225–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maloney E and Hwang JH: Emerging HIFU
applications in cancer therapy. Int J Hyperthermia. 31:302–309.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Alrosan AZ, Heilat GB, Al Subeh ZY,
Alrosan K, Alrousan AF, Abu-Safieh AK and Alabdallat NS: The
effects of statin therapy on brain tumors, particularly glioma: A
review. Anticancer Drugs. 34:985–994. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rendon LF, Tewarie IA, Cote DJ, Gabriel A,
Smith TR, Broekman MLD and Mekary RA: Statins and gliomas: A
systematic review of the preclinical studies and meta-analysis of
the clinical literature. Drugs. 82:293–310. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bayat N, Ebrahimi-Barough S,
Norouzi-Javidan A, Saberi H, Ardakan MMM, Ai A, Soleimannejad M and
Ai J: Anti-inflammatory effects of atorvastatin in human
glioblastoma spheroids cultured in a three-dimensional model:
Possible relevance to glioblastoma treatment. Mol Neurobiol.
55:2102–2110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yongjun Y, Shuyun H, Lei C, Xiangrong C,
Zhilin Y and Yiquan K: Atorvastatin suppresses glioma invasion and
migration by reducing microglial MT1-MMP expression. J
Neuroimmunol. 260:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lübtow MM, Oerter S, Quader S, Jeanclos E,
Cubukova A, Krafft M, Haider MS, Schulte C, Meier L, Rist M, et al:
In vitro blood-brain barrier permeability and cytotoxicity of an
atorvastatin-loaded nanoformulation against glioblastoma in 2D and
3D models. Mol Pharm. 17:1835–1847. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Afshordel S, Kern B, Clasohm J, König H,
Priester M, Weissenberger J, Kögel D and Eckert GP: Lovastatin and
perillyl alcohol inhibit glioma cell invasion, migration, and
proliferation-impact of Ras-/Rho-prenylation. Pharmacol Res.
91:69–77. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang L, Chen T, Dou Y, Zhang S, Liu H,
Khishignyam T, Li X, Zuo D, Zhang Z, Jin M, et al: Atorvastatin
exerts antileukemia activity via inhibiting mevalonate-YAP axis in
K562 and HL60 cells. Front Oncol. 9:10322019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Guo X, Zhou S, Yang Z, Li ZA, Hu W, Dai L,
Liang W and Wang X: Cholesterol metabolism and its implication in
glioblastoma therapy. J Cancer. 13:1745–1757. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Murai T, Maruyama Y, Mio K, Nishiyama H,
Suga M and Sato C: Low cholesterol triggers membrane
microdomain-dependent CD44 shedding and suppresses tumor cell
migration. J Biol Chem. 286:1999–2007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bomben VC, Turner KL, Barclay TTC and
Sontheimer H: Transient receptor potential canonical channels are
essential for chemotactic migration of human malignant gliomas. J
Cell Physiol. 226:1879–1888. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liao AH, Lin WT, Chen HK, Shih CP, Wang CH
and Chu YH: Synergistic effects of combined treatment with
ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin
on head and neck cancer. Head Neck. 43:15–26. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu WP, Shen E, Bai WK, Wang Y and Hu B:
Enhanced antitumor effects of low-frequency ultrasound and
microbubbles in combination with simvastatin by downregulating
caveolin-1 in prostatic DU145 cells. Oncol Lett. 7:2142–2148. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li H, Chen C and Wang D: Low-frequency
ultrasound and microbubbles combined with simvastatin promote the
apoptosis of MCF-7 cells by affecting the LATS1/YAP/RHAMM pathway.
Mol Med Rep. 18:2724–2732. 2018.PubMed/NCBI
|
|
57
|
Kujawska T, Secomski W, Bilmin K, Nowicki
A and Grieb P: Impact of thermal effects induced by ultrasound on
viability of rat C6 glioma cells. Ultrasonics. 54:1366–1372. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Burgess A, Shah K, Hough O and Hynynen K:
Focused ultrasound-mediated drug delivery through the blood-brain
barrier. Expert Rev Neurother. 15:477–491. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Maxfield FR and van Meer G: Cholesterol,
the central lipid of mammalian cells. Curr Opin Cell Biol.
22:422–429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang B and Tontonoz P: Liver X receptors
in lipid signalling and membrane homeostasis. Nat Rev Endocrinol.
14:452–463. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ponce J, de la Ossa NP, Hurtado O, Millan
M, Arenillas JF, Dávalos A and Gasull T: Simvastatin reduces the
association of NMDA receptors to lipid rafts: A
cholesterol-mediated effect in neuroprotection. Stroke.
39:1269–1275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wu H, Jiang H, Lu D, Xiong Y, Qu C, Zhou
D, Mahmood A and Chopp M: Effect of simvastatin on glioma cell
proliferation, migration, and apoptosis. Neurosurgery.
65:1087–1097. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu M, Tang R and Jiang Y: Study on the
function and mechanism of atorvastatin in regulating leukemic cell
apoptosis by the PI3K/Akt pathway. Int J Clin Exp Med. 8:3371–3380.
2015.PubMed/NCBI
|
|
64
|
Yang D, Han Y, Zhang J, Chopp M and
Seyfried DM: Statins enhance expression of growth factors and
activate the PI3K/Akt-mediated signaling pathway after experimental
intracerebral hemorrhage. World J Neurosci. 2:74–80. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lo HW: Targeting Ras-RAF-ERK and its
interactive pathways as a novel therapy for malignant gliomas. Curr
Cancer Drug Targets. 10:840–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Adamičková A, Chomaničová N, Gažová A,
Maďarič J, Červenák Z, Valášková S, Adamička M and Kyselovic J:
Effect of atorvastatin on angiogenesis-related genes VEGF-A, HGF
and IGF-1 and the modulation of PI3K/AKT/mTOR transcripts in
bone-marrow-derived mesenchymal stem cells. Curr Issues Mol Biol.
45:2326–2337. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kumar N and Mandal CC:
Cholesterol-lowering drugs on Akt signaling for prevention of
tumorigenesis. Front Genet. 12:7241492021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Tu J, Fang Y, Han D, Tan X, Jiang H, Gong
X, Wang X, Hong W and Wei W: Activation of nuclear factor-κB in the
angiogenesis of glioma: Insights into the associated molecular
mechanisms and targeted therapies. Cell Prolif. 54:e129292021.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ortego M, Bustos C, Hernández-Presa MA,
Tuñón J, Díaz C, Hernández G and Egido J: Atorvastatin reduces
NF-kappaB activation and chemokine expression in vascular smooth
muscle cells and mononuclear cells. Atherosclerosis. 147:253–261.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cote DJ, Rosner BA, Smith-Warner SA, Egan
KM and Stampfer MJ: Statin use, hyperlipidemia, and risk of glioma.
Eur J Epidemiol. 34:997–1011. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Happold C, Gorlia T, Nabors LB, Erridge
SC, Reardon DA, Hicking C, Picard M, Stupp R and Weller M; EORTC
Brain Tumor Group on behalf of the CENTRIC, CORE Clinical Trial
Groups, : Do statins, ACE inhibitors or sartans improve outcome in
primary glioblastoma? J Neurooncol. 138:163–171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Seliger C, Schaertl J, Gerken M, Luber C,
Proescholdt M, Riemenschneider MJ, Leitzmann MF, Hau P and
Klinkhammer-Schalke M: Use of statins or NSAIDs and survival of
patients with high-grade glioma. PLoS One. 13:e02078582018.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Barth RF and Kaur B: Rat brain tumor
models in experimental neuro-oncology: The C6, 9L, T9, RG2, F98,
BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 94:299–312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
